Close Menu

NEW YORK – Liquid biopsy technology firm Freenome said Wednesday that it has closed an oversubscribed $270 million Series C financing round, led by new investor Bain Capital Life Sciences and existing investor Perceptive Advisors.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.